The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 25,901–26,000 of 31,469
Reyes-López, Z., Olvera‐Hernández, V., Ramos-García, M., Méndez, J. D., Guzmán‐Priego, C. G., Martínez‐López, M. C., García-Vázquez, C., Álvarez-Villagómez, C. S., Juárez‐Rojop, I. E., Díaz-Zagoya, J. C., et al. (2024) · Methods and Protocols · doi:10.3390/mps7050080 · Cited by 3
Park, H., Kim, S., Jang, H., Ha, Y. W., Yun, Y. M., Kim, K. J., Rhee, Y., Kim, H. C., Kim, C. O., & Cho, J. (2024) · Environmental Health · doi:10.1186/s12940-024-01125-8 · Cited by 3
Pacyga, D. C., Jolly, L., Whalen, J., Calafat, A. M., Braun, J. M., Schantz, S. L., & Strakovsky, R. S. (2024) · Environmental Research · doi:10.1016/j.envres.2024.120198 · Cited by 4
Pejovic, S., Shang, Y., Vgontzas, A. N., Fernández‐Mendoza, J., He, F., Li, Y., & Kong, L. (2024) · Journal of Sleep Research · doi:10.1111/jsr.14386 · Cited by 3
Nahm, C. H., Lee, M. H., Fujii, N., Fujii, T., & Choi, J. W. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s478584 · Cited by 3
Chero‐Sandoval, L., Higuera‐Gómez, A., Martínez‐Urbistondo, M., Castejón, R., Mellor‐Pita, S., Moreno‐Torres, V., de Luis, D. A., Cuevas‐Sierra, A., & Martínez, J. A. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14339 · Cited by 3
Perticone, M., Shehaj, E., Suraci, E., Andreozzi, F., & Perticone, F. (2024) · Internal and Emergency Medicine · doi:10.1007/s11739-024-03803-4 · Cited by 3
Sonaglioni, A., Bruno, A., Pusca, I., et al. (2024) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2024.11.001 · Cited by 3
Guido, D., Cerabino, N., Chito, M. D., Stasi, V. D., Nucci, S. D., Shahini, E., Giannuzzi, V., Cozzolongo, R., Coletta, S., Stabile, D., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111911 · Cited by 3
Liu, D., Yin, M., Chen, J., Fu, C., Schneider, M., Nickel, D. M., & Yao, X. (2024) · NMR in Biomedicine · doi:10.1002/nbm.5290 · Cited by 3
Ajiboye, B. O., Famusiwa, C. D., Ojelabi, A. O., et al. (2024) · Pharmacophore · doi:10.51847/xsfzqq25oy · Cited by 3
Azócar-Gallardo, J., Ojeda-Aravena, A., Martín, E. B.-S., Herrera-Valenzuela, T., Tuesta, M., González-Rojas, L., Rico, B. C., & García‐García, J. M. (2024) · Biomolecules · doi:10.3390/biom14111470 · Cited by 5
Laoung-on, J., Anuduang, A., Saenjum, C., et al. (2024) · Life · doi:10.3390/life14111515 · Cited by 3
Totaro, M., Barchetta, I., Sentinelli, F., Cimini, F. A., Palazzi, S., D’Alessandro, F., Spagnolo, L., Dule, S., Barbonetti, A., Cavallo, M. G., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1476751 · Cited by 4
A single-center’s uric acid profile in girls with Turner syndrome
Guo, S., Chen, Q., Zhang, J., Wei, M., Zheng, R., Wang, B., Li, Y., Ma, H., & Jiang, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1442166 · Cited by 2
Aladdin, N., & Ghareib, S. A. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70082 · Cited by 3
RetractedMakri, E. S., Xanthopoulos, K., Pettas, S., Goulas, A., Mavrommatis-Parasidis, P., Makri, E., Tsingotjidou, A., Cheva, A., Ntenti, C., Zacharis, C. K., et al. (2024) · HORMONES · doi:10.1007/s42000-024-00621-3 · Cited by 3
Ryu, H. E., Heo, S., Lee, J. H., Park, B., Han, T., & Kwon, Y. (2025) · Endocrine · doi:10.1007/s12020-024-04154-y · Cited by 3
Circulating trans fatty acids are related to serum levels of NT-proBNP in general population
Wang, X., Chen, X., Jiang, F., Cheng, Y., & Li, Y. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.132974 · Cited by 3
Lin, X., Wu, S., Shi, Y., Lin, W., Yue, F., Lam, S. M., Shui, G., Russell, R., & Zhang, D. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103388 · Cited by 3
Higashioka, M., Sakata, S., Oishi, E., et al. (2025) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.65275 · Cited by 3
Masters, K. S., Wilson, C. L., & Boylan, J. M. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319002 · Cited by 4
Development of a Metabolic Syndrome Prediction Model Using HOMA-IR and Multivariate Factors
Heo, A.-S., & Lee, J. (2025) · Applied Sciences · doi:10.3390/app15062985 · Cited by 3
Nowak, A., Podlewski, J., Hubalewska–Dydejczyk, A., & Trofimiuk-Müldner, M. (2025) · European Thyroid Journal · doi:10.1530/etj-24-0317 · Cited by 3
Park, J., Kim, B., Jeong, M., Jung, H.-H., Hong, G., & Park, S. K. (2025) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2025.1553202 · Cited by 4
Vijay, A., Nivethitha, L., Mooventhan, A., & Manavalan, N. (2025) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_5_25 · Cited by 3
Associations of adiponectin concentrations from birth until late adolescence with insulin resistance
Lee, Y., Harnois‐Leblanc, S., Rifas‐Shiman, S. L., Oken, E., & Hivert, M. (2025) · Pediatric Obesity · doi:10.1111/ijpo.70015 · Cited by 3
Takeda, Y., Furuhashi, M., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., Kumashiro, N., & Sakurai, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1549687 · Cited by 3
Appetitive traits from childhood to adolescence and cardiometabolic health
Costa, A., Pereira, R., Severo, M., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104125 · Cited by 3
Post, A., Dam, W., Groothof, D., Franssen, C. F. M., Bakker, S. J. L., & Dullaart, R. P. F. (2025) · Journal of Internal Medicine · doi:10.1111/joim.20099 · Cited by 4
Corriveau, A., Turcotte, M., Bergeron, A., Lemieux, S., & Labonté, M. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.05.038 · Cited by 3
Competing Risks Analysis of the Finnish Diabetes Prevention Study
Ibrahim, M. M. A., Uusitupa, M. I. J., Tuomilehto, J. O., Lindström, J., Kjellsson, M. C., & Karlsson, M. O. (2025) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70065 · Cited by 4
Verboven, K., Ryckeghem, L. V., Schweiggert, R. M., Steingass, C. B., Gojevic, T., Ruxton, C. H. S., & Hansen, D. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00385-8 · Cited by 3
Chen, H., Yu, X., Wang, X., Huang, J., Wu, J., Zhou, X., Hu, K., & Song, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-02837-4 · Cited by 3
Nilsson, E., Migueles, J. H., Henriksson, P., Nyström, C. D., & Löf, M. (2025) · Acta Paediatrica · doi:10.1111/apa.70276 · Cited by 4
Association of the Mitochondrial DNA 16189 T to C Variant with Lacunar Cerebral Infarction
Liou, C., Lin, T., Feng-mei, H., et al. (2004) · Springer eBooks · doi:10.1007/978-3-662-41088-2_31 · Cited by 3
Maarek, A., Chaim, É. A., & Gobato (2012) · International Journal of General Medicine · doi:10.2147/ijgm.s31433 · Cited by 3
Markantes, G. Κ., Saltamavros, A. D., Vervita, V., Armeni, A. K., Karela, A., Adonakis, G. L., Decavalas, G., & Georgopoulos, N. A. (2011) · Gynecological Endocrinology · doi:10.3109/09513590.2011.569783 · Cited by 3
Síndrome metabólico e inflamación
González, A. S., Bellido, D., Soto, M. B., Pértega-Díaz, S., del Olmo, M. M., & Vidal, O. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73667-1 · Cited by 3
Lewandowski, K. C., Basińska-Lewandowska, M., Bieńkiewicz, M., Randeva, H. S., & Lewiñski, A. (2008) · PubMed · doi:10.82444/warw.33665530 · Cited by 3
Hallikainen, M., Tuomilehto, H., Martikainen, T., Vanninen, E. J., Seppä, J., Kokkarinen, J. I., Randell, J. T., & Gylling, H. (2013) · Cholesterol · doi:10.1155/2013/769457 · Cited by 3
Sympathoadrenal Reactivity to Stress as a Predictor of Cardiovascular Risk Factors
Flaa, A., Rostrup, M., Kjeldsen, S. E., & Eide, I. A. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_33 · Cited by 3
Nag, T., & Ghosh, A. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.11.005 · Cited by 3
Dietary Intervention to Alleviate Acne Severity
Tayel, D. I., Abdelsalam, O. M., El-Garem, Y., Ali, A. E., & Tayel, D. I. (2013) · Cited by 3
Sen, K., Sen, S., Ghatak, S., Majumdar, D., & Bhattacharya, B. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.171291 · Cited by 3
Nutrition in Metabolic Syndrome
Ballesteros-Pomar, M. D. (2006) · Cited by 3
Lewis, J., Jones, L., Legge, M., & Elder, P. (2010) · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · doi:10.1055/s-0030-1265128
Pioglitazone protects HDL 2&3 against oxidation in overweight and obese men
McEneny, J., McPherson, P. A. C., McGinty, A., Hull, S. S., McCance, D. R., & Young, I. S. (2012) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2012.012019 · Cited by 3
Buchmann, N., Norman, K., Demuth, I., & Steinhagen‐Thiessen, E. (2016) · Journal of Laboratory Medicine · doi:10.1515/labmed-2015-0075 · Cited by 3
Momin, A. A., Bankar, M., & Bhoite, G. M. (2014) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-04060109014 · Cited by 3
Wang, J., Lee, C.-L., Lee, W., Lee, I., Lin, S., Lee, W.-L., Liang, K., & Sheu, W. H. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.019 · Cited by 3
Soori, R., Asad, M. R., Khosravi, M., & Abbasian, S. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Wang, N., Ren, C. E., Lou, Y., Le, F., Wang, L., Xz, L., Zhan, Q., Mao, L., Lou, H., & Jin, F. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.11.025 · Cited by 3
Hamouda, H. (2015) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2015.02.00053 · Cited by 3
Etiopathological differentiation of diabetes mellitus in lean, young adults
Kotwal, N., Upreti, V., Kumar, K. V. S. H., & Nachankar, A. S. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.05.014 · Cited by 3
Diabetes self-assessment score and the development of diabetes
Kim, G., Lee, Y., Lee, B., Kang, E. S., Lee, I., Soo, B., & Kim, D. J. (2017) · Medicine · doi:10.1097/md.0000000000007067 · Cited by 3
Lixandru, D., Alexandru, P. R., Mihai, A. D., et al. (2017) · Free Radical Research · doi:10.1080/10715762.2017.1344983 · Cited by 3
Wang, Z., Chen, R., Wang, S., Li, G., Zhu, Z., Huang, Q., Chen, Z., Chen, F., Deng, L., Lan, X., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7898 · Cited by 3
Camilo, D. F., Vasques, A. C. J., Hayashi, K., Tura, A., da Silva, C. D. C., Zambon, M. P., Antonio, M. Â. R. D. G. M., & Geloneze, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.12.013 · Cited by 3
Bouhajja, H., Abdelhédi, R., Amouri, A., Kacem, F. H., Marrakchi, R., Safi, W., Mrabet, H., Chtourou, L., Charfi, N., Fourati, M., et al. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0579 · Cited by 3
Tota, Ł. M., Pilch, W., Piotrowska, A., Pałka, T., & Pilch, P. (2017) · Central European Journal of Sport Sciences and Medicine · doi:10.18276/cej.2017.4-08 · Cited by 3
Kröner, T., Arzt, M. E., Rheinberger, M., Gorski, M., Heid, I. M., Böger, C. A., & Stadler, S. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7617524 · Cited by 3
Elalfy, H., Besheer, T. A., Elhammady, D., Mohamed, M. A., El-Hussiny, M. A.-B., Elkashef, W. F., Eldeek, B. S., & Alsayed, S. A. M. (2018) · Hepatitis Monthly · doi:10.5812/hepatmon.60168 · Cited by 3
Wang, Y., Zhang, J., Ma, Y., Song, X., Li, S., Zhan, X., & Wu, L. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0863-9 · Cited by 3
EFFECT OF CHRONIC AEROBIC EXERCISE TRAINING ON SERUM IRISIN LEVEL IN TYPE 2 DIABETIC RATS
Fathy, M. A. (2017) · Al-Azhar Medical Journal · doi:10.12816/0045176 · Cited by 3
Kwon, J., Kim, W., Lee, S. A., Choi, D., & Park, E. (2019) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000885 · Cited by 4
Hitsumoto, T. (2019) · Cardiology Research · doi:10.14740/cr827 · Cited by 3
Mallard, A. R., Ramos, J. S., Roberts, L. A., et al. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1600022 · Cited by 3
Study of Vitamin D Status and its Correlation with Glycated Haemoglobinin Type 2 Diabetes Mellitus
Aljabri, K. S. (2019) · Journal of Obesity and Diabetes · doi:10.33805/2638-812x.111 · Cited by 3
Hitsumoto, T. (2019) · Cardiology Research · doi:10.14740/cr864 · Cited by 3
Ratliff, J. C., Riedt, C. S., & Fulgoni, V. L. I. (2019) · Nutrition · doi:10.1016/j.nutx.2019.100003 · Cited by 3
Dibai, D. B., Dibai‐Filho, A. V., Carvalho, L. P., et al. (2019) · Physiotherapy Research International · doi:10.1002/pri.1808 · Cited by 3
Categorization of β-cell capacity in patients with obesity via OGTT using K-means clustering
Li, L., Song, Q., & Yang, X. (2020) · Endocrine Connections · doi:10.1530/ec-19-0476 · Cited by 4
Olarotimi, O. J., & Adu, O. A. (2020) · Slovak Journal of Animal Science · Cited by 3
Ferreira, F. G., Juvanhol, L. L., Silva‐Costa, A., & Longo, G. Z. (2020) · American Journal of Human Biology · doi:10.1002/ajhb.23425 · Cited by 3
Sera, N., Nakamura, T., Horie, I., et al. (2020) · Diabetology International · doi:10.1007/s13340-020-00440-y · Cited by 3
Cardoso, C. K. D. S., Peixoto, M. D. R. G., Rodrigues, A. P. D. S., Mendonça, C. R., de Oliveira, C. M., & Silveira, É. A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17197017 · Cited by 3
Kim, H. R. (2020) · Korean Journal of Clinical Laboratory Science · doi:10.15324/kjcls.2020.52.3.165 · Cited by 3
Zubi, Z. B. H., Ibrahim, M. M. M., Alfarisi, H. A. H., Wahab, A. A., Fuaat, A. A., & Mohamad, C. C. (2020) · IIUM Medical Journal Malaysia · doi:10.31436/imjm.v19i3.1661 · Cited by 3
Freitas, M., Silva, V. M., Xavier, S. A., Magalhães, J. T., Marinho, C. M. M., & Cotter, J. B. (2021) · Digestive Diseases · doi:10.1159/000514811 · Cited by 3
Muccini, C., Galli, L., Poli, A., et al. (2021) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002632 · Cited by 3
Weng, J., Chen, M., Guo, R., et al. (2021) · Adipocyte · doi:10.1080/21623945.2021.1886409 · Cited by 3
Stygar, D. M., Sawczyn, T., Dulska, A., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-87293-w · Cited by 3
Peripheral sensory nerve hyperesthesia in women with polycystic ovary syndrome
Magony, S., Nyiraty, S., Tóth, B., Pesei, F., Orosz, A., Ábrahám, G., Kempler, P., Lengyel, C., & Várkonyi, T. T. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03418-7 · Cited by 3
Ige, A. O., Adekanye, O. S., & Adewoye, E. O. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0251 · Cited by 3
Serum IL-17, obesity, and metabolic risk in Mexican young adults
Aradillas-García, C., Monreal‐Escalante, E., Vargas-Morlaes, J. M., Alegría‐Torres, J. A., Rosales‐Mendoza, S., Terán-Garcı́a, M., & Portales‐Pérez, D. P. (2021) · RESPYN Revista de Salud Pública y Nutrición · doi:10.29105/respyn20.3-1 · Cited by 3
Ore, A., Akinloye, O. A., Adeogun, A. I., Ugbaja, R. N., Morifi, E., Makatini, M. M., Moepya, R. J., & Mbhele, T. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13836 · Cited by 4
Kumar, P., & Michael, M. (2021) · Journal of Diabetes & Metabolism · Cited by 3
Minimum distance estimation of the Lehmann receiver operating characteristic curve
Jokiel-Rokita, A., & Topolnicki, R. (2021) · Statistics · doi:10.1080/02331888.2021.1960528 · Cited by 3
The impact of growth hormone replacement therapy on adipokines, but not upon ghrelin
Belceanu, A. D., Bilhă, Ş., Vulpoi, C., et al. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03588-0 · Cited by 3
Ma, Y., Luo, Y., Gong, S., Zhou, X., Li, Y., Liu, W., Zhang, S., Cai, X., Ren, Q., Zhou, L., et al. (2020) · Diabetes · doi:10.2337/db20-0564 · Cited by 3
Soliman, H. M. A. L., Ahmed, S., & Ibrahim, A. (2021) · Egyptian Pediatric Association Gazette · doi:10.1186/s43054-021-00085-9 · Cited by 3
Barreto, I. D. S., dos Santos, R. O., Rocha, R., de Souza, C. A., Almeida, N. S., Vieira, L. V., Silva, R. L. P. D., Sarno, M., Daltro, C., & Cotrim, H. P. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20201016 · Cited by 3
Clément, A., Lacaille, M., Lounis, M. A., Biertho, L. D., Richard, D., Lemieux, I., Bergeron, J., Mounier, C., Joanisse, D. R., & Mauriège, P. (2022) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-021-00855-4 · Cited by 3
Feng, Y., Xu, D., Cai, X., Xu, M., Garbacz, W. G., Ren, S., Jurczak, M. J., Yu, C., Wang, H., & Xie, W. (2022) · Endocrinology · doi:10.1210/endocr/bqac061 · Cited by 3
Allam, A. S., Elmeged, M. L. F. A., Ghaly, S., et al. (2022) · Egyptian Liver Journal · doi:10.1186/s43066-022-00194-z · Cited by 3
Pizano-Zárate, M. L., Horta‐Baas, G., Núñez-Hernández, J. A., et al. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.11.004 · Cited by 3
Persisting prediabetic conditions and glomerular filtration rate – A longitudinal study
Diurlin, S., Lindblad, U., Daka, B., & Hellgren, M. I. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.05.013 · Cited by 3
Acosta, F. M., Sánchez‐Delgado, G., Martínez‐Téllez, B., Osuna‐Prieto, F. J., Méndez-Gutiérrez, A., Aguilera, C. M., Gil, Á., Elvira, J. M. L., & Ruiz, J. R. (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0130 · Cited by 3
Avogbe, P. H., & Sanni, A. (2022) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2022.126010 · Cited by 3
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
